Analysis of ADAM8 expression in breast cancer was extended beyond TNBC to HR−/HER2+ (n = 22), HR+/HER2− (n = 301) and HR+/HER2+ (n = 28) tumors (Table 2 and Fig. 3B). Here, ERBB2 is linked to breast carcinoma.